Biocon Ltd, an indian biotech company are developing
an oral insulin.1N-105 is a novel analog of insulin.
Phase 1 studies show promising results.
A potential competitor for aop.
Biocon Ltd, an indian biotech company are developingan oral...
Add to My Watchlist
What is My Watchlist?